Calendar IconSign Up for Keystone Heart Updates

(813) 530-8200

info@keystoneheart.com

Search

Europe FlagEUUsa FlagUS

Press Releases

Press Releases

Keystone Heart
October 3, 2016

American Journal of Cardiology Reports Data Showing New Brain Lesions in 94% of Patients Following TAVR

CAESAREA, Israel and TAMPA, Fla., Oct. 3, 2016 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for...
Read More
keystone heart
September 19, 2016

TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in Brain Protection in Patients Undergoing TAVR Procedures

CAESAREA, Israel and TAMPA, Fla., Sept. 19, 2016 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for...
Read More
keystone heart
June 15, 2016

Keystone Heart Ltd. Announces First Patient Enrolled in New Study to Protect the Brain During TAVR

Supporting data to be presented at Transcatheter Valve Therapies (TVT) Conference   Keystone Heart Ltd. Announces First Patient Enrolled in...
Read More
May 15, 2015

Data Presented at ACC Demonstrates Benefits of Keystone Heart’s TriGuard™ Cerebral Protection Device During TAVR

Caesarea, Israel and San Diego, California, March 15, 2015 /PRNewswire/ --   American College of Cardiology (ACC) Annual Scientific Session -- March 15 2015/PRNewswire/-- Late breaking...
Read More
April 25, 2012

TAVI Accessory Developer SMT R&D LTD Attracts Seasoned Team, Including CEO, CFO and CMO, Changes Name to Keystone Heart Ltd.

HERZLIYA PITUACH, Israel, April 25, 2012 /PRNewswire/ -- SMT Research & Development, Ltd. ("SMT") today announced the addition of three key executives to its...
Read More
1 2 3 4
Triguard

The Only CE Marked Cerebral Embolic Protection Device Designed to Cover all Three Major Aortic Vessels.

Cerebral Embolic Protection Device

Stay Updated on the latest Blogs from Keystone Heart.

Blog
Skip to content